克里斯普尔和基因编辑:在药物开发中的游戏变革
Abhishek Verma1, Tarun Sharma1, Ankit Awasthi1
1Department of Pharmaceutics, ISF College of Pharmacy, Moga, Punjab 142001, India.
Current pharmaceutical design
|April 8, 2024
概括
基因编辑CRISPR为遗传疾病提供了精确的医学治疗方法,并彻底改变了药物开发. 负责任的实施需要解决道德问题,并确保公平地获得这些变革性技术.
科学领域:
- 生物技术是生物技术.
- 遗传学 遗传学 是一个
- 医学科学 医学科学 医学科学
背景情况:
- 基因编辑CRISPR (集群定期间隔的短Palindromic重复) 是一个革命性的技术.
- 它可以精确地准遗传性疾病,并影响药物开发.
- 它的应用范围包括遗传性疾病,传染病和癌症治疗.
研究的目的:
- 审查CRISPR基因编辑在医学上的广泛影响.
- 突出其在个性化医学,治疗创新和流行病预防方面的潜力.
- 检查其在重塑药物开发过程中的作用.
主要方法:
- 关于CRISPR在各种医学领域的应用的文献综述.
- 分析CRISPR在个性化医学和药物开发中的潜力.
- 讨论道德考虑和商业化挑战.
主要成果:
- 克里斯普尔在各种医疗应用中显示出巨大的潜力.
- 它为治疗遗传疾病和开发新药提供了新的方法.
- 围绕生殖线编辑和访问的伦理辩论至关重要.
结论:
- 克里斯普尔技术正在改变医学,具有巨大的治疗潜力.
- 对道德,商业和公平问题进行导航对于负责任的进步至关重要.
- 合作至关重要,以确保CRISPR有利于未来几代人.
相关概念视频
CRISPR
50.8K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
50.8K
CRISPR and crRNAs
17.0K
Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
17.0K
What is Genetic Engineering?
74.1K
Overview
74.1K
Homologous Recombination
50.5K
The basic reaction of homologous recombination (HR) involves two chromatids that contain DNA sequences sharing a significant stretch of identity. One of these sequences uses a strand from another as a template to synthesize DNA in an enzyme-catalyzed reaction. The final product is a novel amalgamation of the two substrates. To ensure an accurate recombination of sequences, HR is restricted to the S and G2 phases of the cell cycle. At these stages, the DNA has been replicated already and the...
50.5K


